Briefing: U.S. Senator Probes FDA Amid BioNTech Founders' Departure
Strategic angle: The co-founders of BioNTech, known for their Covid-19 vaccine, are set to leave the company to launch a new mRNA-focused venture.
Browse the full archive, newest first.